Cita APA

Xu, X., Eshima, S., Kato, S., Fisher, D. E., Sakurai, H., Hayakawa, Y., & Yokoyama, S. (2019). Rational combination therapy for melanoma with dinaciclib by targeting BAK-dependent cell death. Mol Cancer Ther.

Chicago Style Citation

Xu, Xiaoou, Shizuka Eshima, Shinichiro Kato, David E. Fisher, Hiroaki Sakurai, Yoshihiro Hayakawa, i Satoru Yokoyama. "Rational Combination Therapy for Melanoma With Dinaciclib By Targeting BAK-dependent Cell Death." Mol Cancer Ther 2019.

Cita MLA

Xu, Xiaoou, et al. "Rational Combination Therapy for Melanoma With Dinaciclib By Targeting BAK-dependent Cell Death." Mol Cancer Ther 2019.

Atenció: Aquestes cites poden no estar 100% correctes.